Tamsulosin Hydrochloride Capsule
Product Images NDC 68382-132

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68382-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 01)

Chemical structure of Tamsulosin Hydrochloride, showing its molecular configuration including aromatic rings, ether groups, and the hydrochloride component.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 02)

A pharmacokinetic curve showing plasma concentration (ng/mL) versus time (hours) for Tamsulosin Hydrochloride. The graph compares plasma concentration profiles under fasted and fed conditions, with lines representing each state across a 36-hour time span.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 03)

Line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg treatment, 0.4 mg treatment, and placebo. The Y-axis indicates mean change values and the X-axis shows weeks up to 13, with sample size noted under each time point. The two treatment groups show greater mean change compared to placebo over time.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 04)

A line graph showing mean change over weeks of treatment with Tamsulosin Hydrochloride capsules at 0.4 mg and 0.8 mg doses compared to placebo. The x-axis represents treatment duration in weeks from 0 to 13, and the y-axis represents mean change. Data points for each treatment group are indicated by different symbols: circles for 0.8 mg, triangles for 0.4 mg, and squares for placebo. Sample sizes for each time point are noted below the x-axis.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 05)

A line graph depicting mean change over duration of treatment in weeks, comparing three groups: 0.8 mg treatment, 0.4 mg treatment, and placebo. The y-axis represents mean change in mL/sec, while the x-axis shows weeks of treatment from baseline to last observation. Sample sizes for each time point are indicated below the x-axis.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 06)

A line graph depicting mean change in milliliters per second (mL/sec) over treatment duration in weeks, comparing three treatments: 0.8 mg, 0.4 mg, and placebo. The graph shows data points at weeks 0, 1, 2, 5, 9, and 13, illustrating trends in treatment effects over time.*

FDA Label Image

Tamsulosin HCl Capsules, 0.4 mg (Bcb383f3 196a 4332 9904 08dd8b5da9bd 07)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg by Zydus Pharmaceuticals USA Inc. The label specifies 100 capsules with the NDC number 68382-132-01. It includes a product image of a capsule marked with "0.4 mg" and includes storage instructions and manufacturer information for Cadila Healthcare Ltd, Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.